3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Rectal Neoplasms
3
Ovarian Neoplasms
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Gastrointestinal Stromal Tumors
2
Surgical Wound Infection
1
Peritoneal Neoplasms
1
Neoplasm Metastasis
1
Malignant Neoplasm of Transverse Colon
1
Lung Neoplasms
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Diverticulum
1
Colonic Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Cisplatin
66
Paclitaxel
43
Radiotherapy
39
Carboplatin
29
Fluorouracil
27
Drug Therapy
20
Irinotecan
16
toripalimab
15
pembrolizumab
15
tislelizumab
14
camrelizumab
13
sintilimab
12
Radiotherapy, Intensity-Modulated
11
Albumin-Bound Paclitaxel
11
S 1 (combination)
10
Capecitabine
10
130-nm albumin-bound paclitaxel
10
apatinib
9
Radiation
9
Oxaliplatin
9
Neoadjuvant Therapy
9
Esophagectomy
9
Docetaxel
9
nimotuzumab
8
TP protocol
8
Cetuximab
8
anlotinib
7
Nivolumab
7
nedaplatin
6
Taxes
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Esophageal Squamous Cell Carcinoma
×
Laparoscopy
×
Clear all
NCT02188615
2014-07-11
NACRFMIE
Taizhou Hospital
Phase 2
Unknown
120 enrolled